Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccine
This study reveals that the Qdenga dengue vaccine elicits serotype-skewed and immune imprinting-dependent responses, resulting in poor tetravalent immunity—particularly against DENV-4—and limited gains from a second dose, thereby highlighting critical challenges for its deployment in DENV-naive populations.